Single-cell analysis identifies CPT1a-associated metabolic remodeling in human NK cells during COVID-19.

Natural killer (NK) cells are critical for early antiviral immunity, yet their metabolic regulation during acute human viral infection remains incompletely understood. We analyzed NK cell activation and metabolic reprogramming in 47 vaccinated individuals with mild breakthrough SARS-CoV-2 infection and 20 matched healthy control subjects. COVID-19 patients exhibited elevated plasma interferon α and NK cell activation markers (CD69, CD38), alongside increased basal STAT5 phosphorylation, consistent with IL-15-mediated signaling. Functionally, NK cells from infected subjects displayed heightened cytotoxicity. Metabolic profiling at the single-cell level revealed increased cell size, translational activity, amino acid and glucose uptake, and mitochondrial membrane potential, indicating a globally activated metabolic state specific to NK cells. Using newly developed spectral cytometry panels targeting metabolic regulators, we identified CPT1a as the most discriminative marker between patient and control NK cells, with elevated expression in both CD56bright and CD56dim subsets. CPT1a levels correlated with CD38 expression and with uptake of the fluorescent palmitate analog BODIPY-FL C16, reflecting enhanced long-chain fatty acid oxidation. These changes were absent in B and T lymphocytes. Our findings support that during SARS-CoV-2 infection, human NK cells undergo coordinated cytokine-driven activation and metabolic remodeling, integrating glycolysis and lipid oxidation to support amplified effector function.